Pharmaniaga Berhad operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaniaga Berhad with three other
drug stores in Asia:
Zhejiang Zhenyuan Co., Ltd.
sales of 2.08 billion Chinese Renmimbi [US$334.98 million]
of which 84%
was Medicine Wholesales),
Jiangsu Nhwa Pharmaceutical Company Limited
(2.50 billion Chinese Renmimbi [US$403.32 million]
of which 52%
was Medical Industrial Manufacturing), and
Hua Xia Healthcare Holdings Limited
based in Hong Kong
(2.24 billion Hong Kong Dollars [US$289.37 million]
of which 93%
was Pharmaceutical Wholesale).
During the year ended December of 2014, sales at
Pharmaniaga Berhad were 2.12 billion Malaysian Ringgits (US$562.22 million).
increase of 9.1%
versus 2013, when the company's sales were 1.95 billion Malaysian Ringgits.
This was the fifth consecutive year of sales increases at Pharmaniaga Berhad
(and since 2009, sales have increased a total of 63%).
Sales of Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
2,668.3% in 2014, from
690,000.00 Malaysian Ringgits to 19.10 million Malaysian Ringgits.